Two stocks in Healthcare
Amgen vs Danaher: profit, growth, debt and price compared
Amgen is stronger on 5 of 7 figures: profit margin, sales growth, price for its expected profit, dividend and price trend. Danaher is stronger on 2: debt and analysts' view.
Save both stocks to your watchlist and revisit their latest fundamentals.
| AmgenAMGN | DanaherDHR | |
|---|---|---|
| Net margin | Stronger: 24.1% | 16.9% |
| Revenue growth, past year | Stronger: +8.45% | +8.28% |
| Debt to equity | 376.3% | Stronger: 51.8% |
| Forward P/E | Stronger: 17.7× | 24.5× |
| Dividend yield | Stronger: 2.27% | 0.71% |
| Analysts | Hold · 29 | Stronger: Strong buy · 21 |
| From its 200-day average | Stronger: +14.8% | +9.3% |
Share price over the past year
- Amgen+29.0%
- Danaher+1.4%
18 Nov 202518 Nov 2026
Amgen or Danaher: which is stronger?
- AMGN
Which is more profitable?
Amgen keeps more of each sale as profit: 24.1% against 16.9%.
- AMGN
Which is growing its sales faster?
Amgen is growing its sales faster: +8.45% over the past year, against +8.28%.
- DHR
Which has borrowed less?
Danaher has borrowed less: its debt is 51.8% of what its shareholders own, against 376.3% for Amgen.
- AMGN
Which costs less for the profit it is expected to make?
Amgen costs less for the profit it is expected to make: 17.7× its forward earnings, against 24.5×.
- AMGN
Which pays more in dividends?
Amgen pays more back in dividends for what a share costs: 2.27% a year, against 0.71%.
- DHR
Which do analysts rate higher?
Analysts are warmer on Danaher: Strong buy, against Hold for Amgen.
- AMGN
Which is in the stronger price trend?
Amgen's price is in the stronger trend: 14.8% above its 200-day average, against 9.3% above.
What each company does
AMGNAmgen
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
Reports results on 2 February 2027
DHRDanaher
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
Reports results on 27 January 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.